Literature DB >> 9839152

One-year mortality rates following methadone treatment discharge.

D A Zanis1, G E Woody.   

Abstract

OBJECTIVES: Mortality among 507 patients in a methadone program over a 1-year period was assessed.
METHODS: Mortality was determined for patients in treatment (n = 397), and 12 months later for those discharged (n = 110).
RESULTS: Of discharged patients, 8.2% (9/110) had died, of which six were caused by heroin overdose. None of the discharged clients were in treatment at the time of death. All deaths were among clients who either dropped out of treatment or were discharged unfavorably from the program. Comparatively, only 1% (4/397) of patients died while enrolled in treatment.
CONCLUSION: Death rates, especially overdose, are high among patients who are unfavorably discharged or drop out of methadone treatment. Efforts should be made to retain these at-risk patients in methadone treatment even though treatment response may be suboptimal.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9839152     DOI: 10.1016/s0376-8716(98)00097-0

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  33 in total

Review 1.  Retention in medication-assisted treatment for opiate dependence: A systematic review.

Authors:  Christine Timko; Nicole R Schultz; Michael A Cucciare; Lisa Vittorio; Christina Garrison-Diehn
Journal:  J Addict Dis       Date:  2015-10-14

2.  Characteristics and 9-month outcomes of discharged methadone maintenance clients.

Authors:  Donna M Coviello; Dave A Zanis; Susan A Wesnoski; Kevin G Lynch; Michelle Drapkin
Journal:  J Subst Abuse Treat       Date:  2010-10-30

3.  Pharmacologically assisted treatment of opioid-dependent youth.

Authors:  Anna Pecoraro; Marc Fishman; Michelle Ma; Gvantsa Piralishvili; George E Woody
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

4.  A preliminary investigation of the relationship between dispositional mindfulness and eating disorder symptoms among men in residential substance use treatment.

Authors:  JoAnna Elmquist; Ryan C Shorey; Scott E Anderson; Gregory L Stuart
Journal:  Addict Res Theory       Date:  2016-06-30

5.  Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial.

Authors:  Jane M Liebschutz; Denise Crooks; Debra Herman; Bradley Anderson; Judith Tsui; Lidia Z Meshesha; Shernaz Dossabhoy; Michael Stein
Journal:  JAMA Intern Med       Date:  2014-08       Impact factor: 21.873

6.  Patient-centered methadone treatment: a randomized clinical trial.

Authors:  Robert P Schwartz; Sharon M Kelly; Shannon G Mitchell; Jan Gryczynski; Kevin E O'Grady; Devang Gandhi; Yngvild Olsen; Jerome H Jaffe
Journal:  Addiction       Date:  2016-11-10       Impact factor: 6.526

7.  Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disorders.

Authors:  Geetha A Subramaniam; Maxine L Stitzer; George Woody; Marc J Fishman; Ken Kolodner
Journal:  Drug Alcohol Depend       Date:  2008-09-25       Impact factor: 4.492

8.  Characteristics of inmates witnessing overdose events in prison: implications for prevention in the correctional setting.

Authors:  Carmen E Albizu-García; Adriana Hernández-Viver; Jacqueline Feal; José F Rodríguez-Orengo
Journal:  Harm Reduct J       Date:  2009-07-09

Review 9.  Using behavioral reinforcement to improve methadone treatment participation.

Authors:  Robert K Brooner; Michael Kidorf
Journal:  Sci Pract Perspect       Date:  2002-07

10.  Problem drug use the public health imperative: what some of the literature says.

Authors:  Gez Bevan
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.